Submission Details
| 510(k) Number | K890694 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 10, 1989 |
| Decision Date | March 16, 1989 |
| Days to Decision | 34 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
K890694 is an FDA 510(k) clearance for the BETA-2 MICROGLOBULIN EIA, a System, Test, Beta-2-microglobulin Immunological (Class II — Special Controls, product code JZG), submitted by Serex, Inc. (Englewood, US). The FDA issued a Cleared decision on March 16, 1989, 34 days after receiving the submission on February 10, 1989. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5630.
| 510(k) Number | K890694 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 10, 1989 |
| Decision Date | March 16, 1989 |
| Days to Decision | 34 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
| Product Code | JZG — System, Test, Beta-2-microglobulin Immunological |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5630 |